Loading

Journal of Clinical Nephrology and Research

Use of Statins in the Treatment of Chronic Kidney Disease

Editorial | Open Access Volume 1 | Issue 1 |

  • 1. Department of Medicine, New York Medical College/Westchester Medical Center, USA
+ Show More - Show Less
Corresponding Authors
Wilbert S. Aronow, Department of Medicine, Cardiology Division, New York Medical College/Westchester Medical Center, Macy Pavilion, Room 138, Valhalla, NY 10595, Tele: 914-493-5311; Fax: 914- 235-6274
CITATION

Aronow WS (2014) Use of Statins in the Treatment of Chronic Kidney Disease. J Clin Nephrol Res 1(1): 1001.

INTRODUCTION

Chronic kidney disease (CKD) is associated with cardiovascular disease [1-9]. Efforts need to be made to treat and to prevent cardiovascular events and mortality in patients with CKD [9-13]. The 2011 European Society of Cardiology /European Atherosclerosis Society guidelines state that patients with CKD should be treated as patients at very high risk for cardiovascular disease who need active management of all risk factors [14].

A meta-analysis of 16 randomized controlled trials including 3,594 patients found that stains significantly improved serum lipids in patients with CKD not on dialysis with a trend to be more effective with longer duration of therapy and had less beneficial effect in patients on dialysis with the trend to be less effective with longer duration of therapy [15]. The beneficial effect of statins in preventing the development of renal dysfunction appears to be independent of their lipid-lowering effect [11]. A meta-analysis of 20 clinical trials of 6,452 patients with CKD randomized to statins or placebo showed that statins might exert significant renoprotective effects in CKD patients depending on the duration of treatment but only in patients not receiving dialysis therapy [16]. A meta-analysis of 11 randomized controlled clinical trials included 21, 295 patients with CKD, 6,857 receiving dialysis [17]. In patients with CKD not on dialysis, treatment with statins reduced all-cause mortality 34% (p <0.0001), cardiovascular mortality 31% (p = 0.0012), cardiovascular events 45% (p = 0.0001), and stroke 34% (p = 0.0022) [17]. In patients receiving dialysis, treatment with statins had no effect on all-cause mortality and stroke but reduced cardiovascular mortality 21% (p<0.05) and cardiovascular events 19% (p<0.05) [17].

High-dose statins reduce serum low-density lipoprotein (LDL) cholesterol ≥50% and include atorvastatin 40 mg to 80 mg daily and rosuvastatin 20 mg to 40 mg daily [18]. Moderate-dose statins reduce serum LDL cholesterol 30% to 49% and include atorvastatin 10 mg to 20 mg daily, rosuvastatin 5 mg to 10 mg daily, simvastatin 20 mg to 40 mg daily, pravastatin 40 mg to 80 mg daily, lovastatin 40 mg daily, fluvastatin XL 80 mg daily, fluvastatin 40 mg twice daily, and pitavastatin 2mg to 4 mg daily [18]. Low-dose statins reduce serum LDL cholesterol less than 30% and include simvastatin 10 mg daily, pravastatin 10 mg to 20 mg daily, lovastatin 20 mg daily, fluvastatin 20 mg to 40 mg daily, and pitavastatin 1 mg daily [18].

The 2013 American College of Cardiology (ACC)/ American Heart Association (AHA) guidelines on therapy of hypercholesterolemia state that lifestyle modification must be used both prior to cholesterol-lowering drug therapy and together with use of cholesterol-lowering drug therapy [18]. Lifestyle modification includes a heart healthy diet, regular exercise, avoidance of tobacco products, and an ideal body weight [18].

These guidelines support the use of statins in patients with clinical evidence of atherosclerotic cardiovascular disease (ASCVD). ASCVD includes acute coronary syndromes, a history of myocardial infarction, stable or unstable angina pectoris, coronary or other arterial revascularization, stroke, transient ischemic attack, or atherosclerotic peripheral arterial disease [18]. These guidelines recommend use of high-dose statins in men and in women aged 75 years and younger with evidence of ASCVD with a class I indication. If high-dose statins are associated with adverse effects in patients with ASCVD, moderate-dose statins are recommended if tolerated with a class I indication. In patients older than 75 years with clinical ASCVD, use of high-dose or moderate-dose statins has a class IIa indication [18].

Patients with New York Heart Association class II, III, or IV heart failure and patients undergoing maintenance hemodialysis are unlikely to benefit from treatment from statins. No recommendation was made regarding initiation or continuation of statin therapy in these patients [18].

The ACC/AHA guidelines also recommend treating persons aged 21 years and older with a serum LDL cholesterol ≥190 mg/ dL (group 2) with high-dose statins with a class I indication. For persons unable to tolerate high-dose statins, use the maximum tolerated dose of statin [18].

Patients aged 40 to 75 years with serum LDL cholesterol of 70 to 189 mg/dL without ASCVD or diabetes mellitus and an estimated 10-year ASCVD risk of ≥7.5% should be treated with high-dose or moderate-dose statins with a class I indication [18]. It is reasonable to treat persons aged 40 to 75 years with a seum LDL cholesterol of 70 to 189 mg/dL without ASCVD or diabetes mellitus and an estimated 10-year ASCVD risk of 5% to 7.4% with moderate-dose statins [18].

Bile acid sequestrants should not be used in persons with fasting serum triglycerides ≥300 mg/dL or type III hyperlipoproteinemia because severe triglyceride increases may occur (class III indication harm) [18]. Gemfibrozil is contraindicated in patients treated with statins (class III indication harm). Fenofibrate may be considered in patients on low-dose statins or moderate-dose statins with serum triglycerides ≥ 500 mg/dL with a class IIb indication [18]. Fenofibrate is contraindicated in these patients if the estimated glomerular filtration rate is less than 30 mL/minute/1.73 m2 (class III indication harm) [18]. If the the estimated glomerular filtration rate is between 30 and 59 mL/minute/1.73 m2 , the fenofibrate dose should not exceed 54 mg/day [18]. If omega-3 fatty acids are used for the treatment of serum triglycerides ≥500 mg/dL, the patient should be evaluated for gastrointestinal disturbances, skin changes, and bleeding [18].

The ACC/AHA guidelines committee also found no evidence that titration of statins or combination drug therapy to achieve specific LDL cholesterol levels or non-HDL cholesterol levels or percent decrease improved ASCVD outcomes. Therefore, the guidelines do not recommend their use [18].

The Kidney Disease: Improving Global Outcomes (KDIGO) 2013 guidelines recommend use of statins in patients aged 50 years and older with an estimated glomerular filtration rate less than 60 ml/min/1.73 m2 but not treated with chronic dialysis or kidney transplantation [21]. In patients aged 18 to 49 years with CKD but not treated with chronic dialysis or kidney transplantation, these guidelines recommend treatment with statins in patients with one or more of the following: known coronary artery disease, diabetes mellitus, prior ischemic stroke, or an estimated 10-year incidence of coronary death or nonfatal myocardial infarction >10% [21]. These guidelines suggest not starting statins in patients receiving chronic dialysis but continuing statins in these patients if they are already being treated with statins [21]. These guidelines suggest treatment with statins in adult kidney transplant recipients [21]. In adults with CKD, follow-up measurements of serum lipids are not needed for the majority of patients [21].

On the basis of the available data, I favor the ACC/AHA 2013 guidelines for the management of patients with CKD not being treated with chronic dialysis or kidney transplantation [18]. However, I favor the KDIGO 2013 guidelines in patients who are being treated with chronic dialysis or kidney transplantation [21].

REFERENCES

1. Aronow WS, Ahn C, Mecando AD, Epstein S. Prevalence of coronary artery disease, complex ventricular arrhythmias, and silent myocardial ischemia and incidence of new coronary events in older persons with chronic renal insufficiency and with normal renal function. Am J Cardiol 2000; 86: 1142-1143.

2. Das M, Aronow WS, McClung JA, Belkin RN. Increased prevalence of coronary artery disease, silent myocardial ischemia, complex ventricular arrhythmias, atrial fibrillation, left ventricular hypertrophy, mitral annular calcium, and aortic valve calcium in patients with chronic renal insufficiency. Cardiol Rev 2006; 14: 14-17.

3. Khalique O, Aronow WS, Ahn C, Mazar M, Schair B, Shao J, et al. Relation of moderate or severe reduction in glomerular filtration rate to number of coronary arteries narrowed >50% in patients undergoing coronary angiography for suspected coronary artery disease. Am J Cardiol. 2007; 100: 415-416.

4. Duncan K, Aronow WS, Babu S. Prevalence of moderate or severe chronic kidney disease in patients with severe peripheral arterial disease versus mild or moderate peripheral arterial disease. Med Sci Monit. 2010; 16: CR584-587.

5. Banach M, Serban C, Aronow WS, et al. Lipids, blood pressure, and kidney 2013. Int Urol Nephrol In press.

6. Olechnowicz-Tietz S, Gluba A, Paradowska A, Banach M, Rysz J. The risk of atherosclerosis in patients with chronic kidney disease. Int Urol Nephrol. 2013; 45: 1605-1612.

7. Gluba A, Mikhailidis DP, Lip GY, Hannam S, Rysz J, Banach M. Metabolic syndrome and renal disease. Int J Cardiol. 2013; 164: 141-150.

8. Franczyk-Skóra B, Gluba A, Banach M, Rozentryt P, PoloÅ„ski L, Rysz J. Acute coronary syndromes in patients with chronic kidney disease. Curr Vasc Pharmacol. 2013; 11: 758-767.

9. Franczyk-Skóra B1, Gluba A1, Banach M2, Rysz J1. Treatment of non-ST-elevation myocardial infarction and ST-elevation myocardial infarction in patients with chronic kidney disease. Arch Med Sci. 2013; 9: 1019-1027.

10. Rysz J, Aronow WS, Stolarek RS, Hannam S, Mikhailidis DP, Banach M. Nephroprotective and clinical potential of statins in dialyzed patients. Expert Opin Ther Targets. 2009; 13: 541-550.

11. Sukhija R, Bursac Z, Kakar P, Fink L, Fort C, Satwani S, et al. Effect of statins on the development of renal dysfunction. Am J Cardiol. 2008; 101: 975-979.

12. Athyros VG, Katsiki N, Tziomalos K, Gossios TD, Theocharidou E, Gkaliagkousi E, et al. Statins and cardiovascular outcomes in elderly and younger patients with coronary artery disease: a post hoc analysis of the GREACE study. Arch Med Sci. 2013; 9: 418-426.

13. Gluba A, Rysz J, Banach M. Statins in patients with chronic kidney disease: why, who and when? Expert Opin Pharmacother. 2010; 11: 2665-2674.

14. Catapano AL, Reiner Z, De Backer G, Graham I, Taskinen MR, Wiklund O, et al. ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis. 2011; 217: 3-46.

15. Nikolic D, Nikfar S, Salari P, Rizzo M, Ray KK, Pencina MJ, et al. Effects of statins on lipid profile in chronic kidney disease patients: a metaanalysis of randomized controlled trials. Curr Med Res Opin. 2013; 29: 435-451.

16. Nikolic D, Banach M, Nikfar S, Salari P, Mikhailidis DP, Toth PP, et al. A meta-analysis of the role of statins on renal outcomes in patients with chronic kidney disease. Is the duration of therapy important? Int J Cardiol. 2013; 168: 5437-5447.

17. Barylski M, Nikfar S, Mikhailidis DP, Toth PP, Salari P, Ray KK, et al. Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy--a meta-analysis of 11 randomized controlled trials involving 21,295 participants. Pharmacol Res. 2013; 72: 35-44.

18. Stone NJ, Robinson J, Lichtenstein AH, Merz CNB, Blum CB, Eckel RH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation, American Pharmacists Association, American Society for Preventive Cardiology, Association of Black Cardiologists, Preventive Cardiovascular Nurses Association, and Women Heart: The National Coalition for Women with Heart Disease. J Am Coll Cardiol. 2013; 1-85.

19. CV Risk Calculator. The American Heart Association and the American College of Cardiology.

20. 2013 Prevention Guidelines ASCVD Risk Estimator.

21. Tonelli M, Wanner C, for the Kidney Disease Improving Global Outcomes Lipid Guideline Development Work Group Members. Lipid management in chronic kidney disease: synopsis of the Kidney Disease: Improving Global outcomes 2013 Clinical Practice Guideline. Ann Intern Med. 2013.

Aronow WS (2014) Use of Statins in the Treatment of Chronic Kidney Disease. J Clin Nephrol Res 1(1): 1001.

Received : 14 Feb 2014
Accepted : 17 Feb 2014
Published : 19 Feb 2014
Journals
Annals of Otolaryngology and Rhinology
ISSN : 2379-948X
Launched : 2014
JSM Schizophrenia
Launched : 2016
Journal of Nausea
Launched : 2020
JSM Internal Medicine
Launched : 2016
JSM Hepatitis
Launched : 2016
JSM Oro Facial Surgeries
ISSN : 2578-3211
Launched : 2016
Journal of Human Nutrition and Food Science
ISSN : 2333-6706
Launched : 2013
JSM Regenerative Medicine and Bioengineering
ISSN : 2379-0490
Launched : 2013
JSM Spine
ISSN : 2578-3181
Launched : 2016
Archives of Palliative Care
ISSN : 2573-1165
Launched : 2016
JSM Nutritional Disorders
ISSN : 2578-3203
Launched : 2017
Annals of Neurodegenerative Disorders
ISSN : 2476-2032
Launched : 2016
Journal of Fever
ISSN : 2641-7782
Launched : 2017
JSM Bone Marrow Research
ISSN : 2578-3351
Launched : 2016
JSM Mathematics and Statistics
ISSN : 2578-3173
Launched : 2014
Journal of Autoimmunity and Research
ISSN : 2573-1173
Launched : 2014
JSM Arthritis
ISSN : 2475-9155
Launched : 2016
JSM Head and Neck Cancer-Cases and Reviews
ISSN : 2573-1610
Launched : 2016
JSM General Surgery Cases and Images
ISSN : 2573-1564
Launched : 2016
JSM Anatomy and Physiology
ISSN : 2573-1262
Launched : 2016
JSM Dental Surgery
ISSN : 2573-1548
Launched : 2016
Annals of Emergency Surgery
ISSN : 2573-1017
Launched : 2016
Annals of Mens Health and Wellness
ISSN : 2641-7707
Launched : 2017
Journal of Preventive Medicine and Health Care
ISSN : 2576-0084
Launched : 2018
Journal of Chronic Diseases and Management
ISSN : 2573-1300
Launched : 2016
Annals of Vaccines and Immunization
ISSN : 2378-9379
Launched : 2014
JSM Heart Surgery Cases and Images
ISSN : 2578-3157
Launched : 2016
Annals of Reproductive Medicine and Treatment
ISSN : 2573-1092
Launched : 2016
JSM Brain Science
ISSN : 2573-1289
Launched : 2016
JSM Biomarkers
ISSN : 2578-3815
Launched : 2014
JSM Biology
ISSN : 2475-9392
Launched : 2016
Archives of Stem Cell and Research
ISSN : 2578-3580
Launched : 2014
Annals of Clinical and Medical Microbiology
ISSN : 2578-3629
Launched : 2014
JSM Pediatric Surgery
ISSN : 2578-3149
Launched : 2017
Journal of Memory Disorder and Rehabilitation
ISSN : 2578-319X
Launched : 2016
JSM Tropical Medicine and Research
ISSN : 2578-3165
Launched : 2016
JSM Head and Face Medicine
ISSN : 2578-3793
Launched : 2016
JSM Cardiothoracic Surgery
ISSN : 2573-1297
Launched : 2016
JSM Bone and Joint Diseases
ISSN : 2578-3351
Launched : 2017
JSM Bioavailability and Bioequivalence
ISSN : 2641-7812
Launched : 2017
JSM Atherosclerosis
ISSN : 2573-1270
Launched : 2016
Journal of Genitourinary Disorders
ISSN : 2641-7790
Launched : 2017
Journal of Fractures and Sprains
ISSN : 2578-3831
Launched : 2016
Journal of Autism and Epilepsy
ISSN : 2641-7774
Launched : 2016
Annals of Marine Biology and Research
ISSN : 2573-105X
Launched : 2014
JSM Health Education & Primary Health Care
ISSN : 2578-3777
Launched : 2016
JSM Communication Disorders
ISSN : 2578-3807
Launched : 2016
Annals of Musculoskeletal Disorders
ISSN : 2578-3599
Launched : 2016
Annals of Virology and Research
ISSN : 2573-1122
Launched : 2014
JSM Renal Medicine
ISSN : 2573-1637
Launched : 2016
Journal of Muscle Health
ISSN : 2578-3823
Launched : 2016
JSM Genetics and Genomics
ISSN : 2334-1823
Launched : 2013
JSM Anxiety and Depression
ISSN : 2475-9139
Launched : 2016
Clinical Journal of Heart Diseases
ISSN : 2641-7766
Launched : 2016
Annals of Medicinal Chemistry and Research
ISSN : 2378-9336
Launched : 2014
JSM Pain and Management
ISSN : 2578-3378
Launched : 2016
JSM Women's Health
ISSN : 2578-3696
Launched : 2016
Clinical Research in HIV or AIDS
ISSN : 2374-0094
Launched : 2013
Journal of Endocrinology, Diabetes and Obesity
ISSN : 2333-6692
Launched : 2013
Journal of Substance Abuse and Alcoholism
ISSN : 2373-9363
Launched : 2013
JSM Neurosurgery and Spine
ISSN : 2373-9479
Launched : 2013
Journal of Liver and Clinical Research
ISSN : 2379-0830
Launched : 2014
Journal of Drug Design and Research
ISSN : 2379-089X
Launched : 2014
JSM Clinical Oncology and Research
ISSN : 2373-938X
Launched : 2013
JSM Bioinformatics, Genomics and Proteomics
ISSN : 2576-1102
Launched : 2014
JSM Chemistry
ISSN : 2334-1831
Launched : 2013
Journal of Trauma and Care
ISSN : 2573-1246
Launched : 2014
JSM Surgical Oncology and Research
ISSN : 2578-3688
Launched : 2016
Annals of Food Processing and Preservation
ISSN : 2573-1033
Launched : 2016
Journal of Radiology and Radiation Therapy
ISSN : 2333-7095
Launched : 2013
JSM Physical Medicine and Rehabilitation
ISSN : 2578-3572
Launched : 2016
Annals of Clinical Pathology
ISSN : 2373-9282
Launched : 2013
Annals of Cardiovascular Diseases
ISSN : 2641-7731
Launched : 2016
Journal of Behavior
ISSN : 2576-0076
Launched : 2016
Annals of Clinical and Experimental Metabolism
ISSN : 2572-2492
Launched : 2016
Clinical Research in Infectious Diseases
ISSN : 2379-0636
Launched : 2013
JSM Microbiology
ISSN : 2333-6455
Launched : 2013
Journal of Urology and Research
ISSN : 2379-951X
Launched : 2014
Journal of Family Medicine and Community Health
ISSN : 2379-0547
Launched : 2013
Annals of Pregnancy and Care
ISSN : 2578-336X
Launched : 2017
JSM Cell and Developmental Biology
ISSN : 2379-061X
Launched : 2013
Annals of Aquaculture and Research
ISSN : 2379-0881
Launched : 2014
Clinical Research in Pulmonology
ISSN : 2333-6625
Launched : 2013
Journal of Immunology and Clinical Research
ISSN : 2333-6714
Launched : 2013
Annals of Forensic Research and Analysis
ISSN : 2378-9476
Launched : 2014
JSM Biochemistry and Molecular Biology
ISSN : 2333-7109
Launched : 2013
Annals of Breast Cancer Research
ISSN : 2641-7685
Launched : 2016
Annals of Gerontology and Geriatric Research
ISSN : 2378-9409
Launched : 2014
Journal of Sleep Medicine and Disorders
ISSN : 2379-0822
Launched : 2014
JSM Burns and Trauma
ISSN : 2475-9406
Launched : 2016
Chemical Engineering and Process Techniques
ISSN : 2333-6633
Launched : 2013
Annals of Clinical Cytology and Pathology
ISSN : 2475-9430
Launched : 2014
JSM Allergy and Asthma
ISSN : 2573-1254
Launched : 2016
Journal of Neurological Disorders and Stroke
ISSN : 2334-2307
Launched : 2013
Annals of Sports Medicine and Research
ISSN : 2379-0571
Launched : 2014
JSM Sexual Medicine
ISSN : 2578-3718
Launched : 2016
Annals of Vascular Medicine and Research
ISSN : 2378-9344
Launched : 2014
JSM Biotechnology and Biomedical Engineering
ISSN : 2333-7117
Launched : 2013
Journal of Hematology and Transfusion
ISSN : 2333-6684
Launched : 2013
JSM Environmental Science and Ecology
ISSN : 2333-7141
Launched : 2013
Journal of Cardiology and Clinical Research
ISSN : 2333-6676
Launched : 2013
JSM Nanotechnology and Nanomedicine
ISSN : 2334-1815
Launched : 2013
Journal of Ear, Nose and Throat Disorders
ISSN : 2475-9473
Launched : 2016
JSM Ophthalmology
ISSN : 2333-6447
Launched : 2013
Journal of Pharmacology and Clinical Toxicology
ISSN : 2333-7079
Launched : 2013
Annals of Psychiatry and Mental Health
ISSN : 2374-0124
Launched : 2013
Medical Journal of Obstetrics and Gynecology
ISSN : 2333-6439
Launched : 2013
Annals of Pediatrics and Child Health
ISSN : 2373-9312
Launched : 2013
JSM Clinical Pharmaceutics
ISSN : 2379-9498
Launched : 2014
JSM Foot and Ankle
ISSN : 2475-9112
Launched : 2016
JSM Alzheimer's Disease and Related Dementia
ISSN : 2378-9565
Launched : 2014
Journal of Addiction Medicine and Therapy
ISSN : 2333-665X
Launched : 2013
Journal of Veterinary Medicine and Research
ISSN : 2378-931X
Launched : 2013
Annals of Public Health and Research
ISSN : 2378-9328
Launched : 2014
Annals of Orthopedics and Rheumatology
ISSN : 2373-9290
Launched : 2013
Annals of Community Medicine and Practice
ISSN : 2475-9465
Launched : 2014
Annals of Biometrics and Biostatistics
ISSN : 2374-0116
Launched : 2013
JSM Clinical Case Reports
ISSN : 2373-9819
Launched : 2013
Journal of Cancer Biology and Research
ISSN : 2373-9436
Launched : 2013
Journal of Surgery and Transplantation Science
ISSN : 2379-0911
Launched : 2013
Journal of Dermatology and Clinical Research
ISSN : 2373-9371
Launched : 2013
JSM Gastroenterology and Hepatology
ISSN : 2373-9487
Launched : 2013
Annals of Nursing and Practice
ISSN : 2379-9501
Launched : 2014
JSM Dentistry
ISSN : 2333-7133
Launched : 2013
Author Information X